Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1992 Jul 15;285(Pt 2):419–425. doi: 10.1042/bj2850419

Positive co-operative binding at two weak lysine-binding sites governs the Glu-plasminogen conformational change.

U Christensen 1, L Mølgaard 1
PMCID: PMC1132805  PMID: 1322132

Abstract

The kinetics of a series of Glu-plasminogen ligand-binding processes were investigated at pH 7.8 and 25 degrees C (in 0.1 M-NaCl). The ligands include compounds analogous to C-terminal lysine residues and to normal lysine residues. Changes of the Glu-plasminogen protein fluorescence were measured in a stopped-flow instrument as a function of time after rapid mixing of Glu-plasminogen and ligand at various concentrations. Large positive fluorescence changes (approximately 10%) accompany the ligand-induced conformational changes of Glu-plasminogen resulting from binding at weak lysine-binding sites. Detailed studies of the concentration-dependencies of the equilibrium signals and the rate constants of the process induced by various ligands showed the conformational change to involve two sites in a concerted positive co-operative process with three steps: (i) binding of a ligand at a very weak lysine-binding site that preferentially, but not exclusively, binds C-terminal-type lysine ligands, (ii) the rate-determining actual-conformational-change step and (iii) binding of one more lysine ligand at a second weak lysine-binding site that then binds the ligand more tightly. Further, totally independent initial small negative fluorescence changes (approximately 2-4%) corresponding to binding at the strong lysine-binding site of kringle 1 [Sottrup-Jensen, Claeys, Zajdel, Petersen & Magnusson (1978) Prog. Chem. Fibrinolysis Thrombolysis 3, 191-209] were observed for the C-terminal-type ligands. The finding that the conformational change in Glu-plasminogen involves two weak lysine-binding sites indicates that the effect cannot be assigned to any single kringle and that the problem of whether kringle 4 or kringle 5 is responsible for the process resolves itself. Probably kringle 4 and 5 are both participating. The involvement of two lysine binding-sites further makes the high specificity of Glu-plasminogen effectors more conceivable.

Full text

PDF
422

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alkjaersig N. The purification and properties of human plasminogen. Biochem J. 1964 Oct;93(1):171–182. doi: 10.1042/bj0930171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Christensen U. C-terminal lysine residues of fibrinogen fragments essential for binding to plasminogen. FEBS Lett. 1985 Mar 11;182(1):43–46. doi: 10.1016/0014-5793(85)81150-9. [DOI] [PubMed] [Google Scholar]
  3. Christensen U. Kinetic studies of the urokinase-catalysed conversion of NH2-terminal glutamic acid plasminogen to plasmin. Biochim Biophys Acta. 1977 Apr 12;481(2):638–647. doi: 10.1016/0005-2744(77)90297-2. [DOI] [PubMed] [Google Scholar]
  4. Christensen U., Mølgaard L. Stopped-flow fluorescence kinetic studies of Glu-plasminogen. Conformational changes triggered by AH-site ligand binding. FEBS Lett. 1991 Jan 28;278(2):204–206. doi: 10.1016/0014-5793(91)80117-l. [DOI] [PubMed] [Google Scholar]
  5. Christensen U. The AH-site of plasminogen and two C-terminal fragments. A weak lysine-binding site preferring ligands not carrying a free carboxylate function. Biochem J. 1984 Oct 15;223(2):413–421. doi: 10.1042/bj2230413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Christensen U. Urokinase-catalysed plasminogen activation. Effects of ligands binding to the AH-site of plasminogen. Biochim Biophys Acta. 1988 Nov 23;957(2):258–265. doi: 10.1016/0167-4838(88)90281-6. [DOI] [PubMed] [Google Scholar]
  7. Deutsch D. G., Mertz E. T. Plasminogen: purification from human plasma by affinity chromatography. Science. 1970 Dec 4;170(3962):1095–1096. doi: 10.1126/science.170.3962.1095. [DOI] [PubMed] [Google Scholar]
  8. Hoylaerts M., Rijken D. C., Lijnen H. R., Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem. 1982 Mar 25;257(6):2912–2919. [PubMed] [Google Scholar]
  9. Lerch P. G., Rickli E. E., Lergier W., Gillessen D. Localization of individual lysine-binding regions in human plasminogen and investigations on their complex-forming properties. Eur J Biochem. 1980;107(1):7–13. doi: 10.1111/j.1432-1033.1980.tb04617.x. [DOI] [PubMed] [Google Scholar]
  10. Lijnen H. R., Hoylaerts M., Collen D. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein. J Biol Chem. 1980 Nov 10;255(21):10214–10222. [PubMed] [Google Scholar]
  11. Llinas M., De Marco A., Hochschwender S. M., Laursen R. A. A 1H-NMR study of isolated domains from human plasminogen. Structural homology between kringles 1 and 4. Eur J Biochem. 1983 Oct 3;135(3):379–391. doi: 10.1111/j.1432-1033.1983.tb07665.x. [DOI] [PubMed] [Google Scholar]
  12. Lucas M. A., Fretto L. J., McKee P. A. The binding of human plasminogen to fibrin and fibrinogen. J Biol Chem. 1983 Apr 10;258(7):4249–4256. [PubMed] [Google Scholar]
  13. Mangel W. F., Lin B. H., Ramakrishnan V. Characterization of an extremely large, ligand-induced conformational change in plasminogen. Science. 1990 Apr 6;248(4951):69–73. doi: 10.1126/science.2108500. [DOI] [PubMed] [Google Scholar]
  14. Markus G., DePasquale J. L., Wissler F. C. Quantitative determination of the binding of epsilon-aminocaproic acid to native plasminogen. J Biol Chem. 1978 Feb 10;253(3):727–732. [PubMed] [Google Scholar]
  15. Markus G., Evers J. L., Hobika G. H. Comparison of some properties of native (Glu) and modified (Lys) human plasminogen. J Biol Chem. 1978 Feb 10;253(3):733–739. [PubMed] [Google Scholar]
  16. Markus G., Priore R. L., Wissler F. C. The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation. J Biol Chem. 1979 Feb 25;254(4):1211–1216. [PubMed] [Google Scholar]
  17. Matsuka Y. V., Novokhatny V. V., Kudinov S. A. Fluorescence spectroscopic analysis of ligand binding to kringle 1 + 2 + 3 and kringle 1 fragments from human plasminogen. Eur J Biochem. 1990 May 31;190(1):93–97. doi: 10.1111/j.1432-1033.1990.tb15550.x. [DOI] [PubMed] [Google Scholar]
  18. Motta A., Laursen R. A., Llinás M., Tulinsky A., Park C. H. Complete assignment of the aromatic proton magnetic resonance spectrum of the kringle 1 domain from human plasminogen: structure of the ligand-binding site. Biochemistry. 1987 Jun 30;26(13):3827–3836. doi: 10.1021/bi00387a014. [DOI] [PubMed] [Google Scholar]
  19. Motta A., Laursen R. A., Llinás M., Tulinsky A., Park C. H. Complete assignment of the aromatic proton magnetic resonance spectrum of the kringle 1 domain from human plasminogen: structure of the ligand-binding site. Biochemistry. 1987 Jun 30;26(13):3827–3836. doi: 10.1021/bi00387a014. [DOI] [PubMed] [Google Scholar]
  20. Nieuwenhuizen W., Traas D. W. A rapid and simple method for the separation of four molecular forms of human plasminogen. Thromb Haemost. 1989 Apr 25;61(2):208–210. [PubMed] [Google Scholar]
  21. Peltz S. W., Hardt T. A., Mangel W. F. Positive regulation of activation of plasminogen by urokinase: differences in Km for (glutamic acid)-plasminogen and lysine-plasminogen and effect of certain alpha, omega-amino acids. Biochemistry. 1982 May 25;21(11):2798–2804. doi: 10.1021/bi00540a035. [DOI] [PubMed] [Google Scholar]
  22. Petersen L. C., Brender J., Suenson E. Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation. Biochem J. 1985 Jan 1;225(1):149–158. doi: 10.1042/bj2250149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rickli E. E., Otavsky W. I. A new method of isolation and some properties of the heavy chain of human plasmin. Eur J Biochem. 1975 Nov 15;59(2):441–447. doi: 10.1111/j.1432-1033.1975.tb02472.x. [DOI] [PubMed] [Google Scholar]
  24. Rákóczi I., Wiman B., Collen D. On the biological significance of the specific interaction between fibrin, plasminogen and antiplasmin. Biochim Biophys Acta. 1978 May 3;540(2):295–300. doi: 10.1016/0304-4165(78)90142-3. [DOI] [PubMed] [Google Scholar]
  25. Rånby M. Studies on the kinetics of plasminogen activation by tissue plasminogen activator. Biochim Biophys Acta. 1982 Jun 24;704(3):461–469. doi: 10.1016/0167-4838(82)90068-1. [DOI] [PubMed] [Google Scholar]
  26. Suenson E., Lützen O., Thorsen S. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis. Eur J Biochem. 1984 May 2;140(3):513–522. doi: 10.1111/j.1432-1033.1984.tb08132.x. [DOI] [PubMed] [Google Scholar]
  27. Thewes T., Constantine K., Byeon I. J., Llinás M. Ligand interactions with the kringle 5 domain of plasminogen. A study by 1H NMR spectroscopy. J Biol Chem. 1990 Mar 5;265(7):3906–3915. [PubMed] [Google Scholar]
  28. Thorsen S. Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-aminocarboxylic acids. Biochim Biophys Acta. 1975 May 30;393(1):55–65. doi: 10.1016/0005-2795(75)90216-0. [DOI] [PubMed] [Google Scholar]
  29. Thorsen S., Kok P., Astrup T. Reversible and irreversible alterations of human plasminogen indicated by changes in susceptibility to plasminogen activators and in response to epsilon-aminocaproic acid. Thromb Diath Haemorrh. 1974 Dec 31;32(2-3):325–340. [PubMed] [Google Scholar]
  30. Trexler M., Váli Z., Patthy L. Structure of the omega-aminocarboxylic acid-binding sites of human plasminogen. Arginine 70 and aspartic acid 56 are essential for binding of ligand by kringle 4. J Biol Chem. 1982 Jul 10;257(13):7401–7406. [PubMed] [Google Scholar]
  31. Violand B. N., Byrne R., Castellino F. J. The effect of alpha-,omega-amino acids on human plasminogen structure and activation. J Biol Chem. 1978 Aug 10;253(15):5395–5401. [PubMed] [Google Scholar]
  32. Váli Z., Patthy L. Location of the intermediate and high affinity omega-aminocarboxylic acid-binding sites in human plasminogen. J Biol Chem. 1982 Feb 25;257(4):2104–2110. [PubMed] [Google Scholar]
  33. Wiman B., Collen D. Molecular mechanism of physiological fibrinolysis. Nature. 1978 Apr 6;272(5653):549–550. doi: 10.1038/272549a0. [DOI] [PubMed] [Google Scholar]
  34. Wiman B., Lijnen H. R., Collen D. On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen. Biochim Biophys Acta. 1979 Jul 25;579(1):142–154. doi: 10.1016/0005-2795(79)90094-1. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES